These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6333809)
21. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium. Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR J Cardiovasc Pharmacol; 1986; 8(5):957-66. PubMed ID: 2429097 [TBL] [Abstract][Full Text] [Related]
22. New directions in antiarrhythmic drug therapy. Somberg JC Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082 [TBL] [Abstract][Full Text] [Related]
23. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs. Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil]. Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987 [TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia. Kamiya J; Ishii M; Katakami T Jpn J Pharmacol; 1992 Feb; 58(2):107-15. PubMed ID: 1507517 [TBL] [Abstract][Full Text] [Related]
27. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782 [TBL] [Abstract][Full Text] [Related]
28. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: implications for serial drug testing. McPherson CA; Rosenfeld LE; Batsford WP Am J Cardiol; 1985 Mar; 55(6):689-95. PubMed ID: 3976510 [TBL] [Abstract][Full Text] [Related]
29. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia. Sheldon RS; Rahmberg M; Duff HJ J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs. Krejcy K; Krumpl G; Todt H; Raberger G J Pharm Pharmacol; 1992 Apr; 44(4):349-54. PubMed ID: 1355549 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764 [TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia. Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784 [TBL] [Abstract][Full Text] [Related]
33. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation. Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715 [TBL] [Abstract][Full Text] [Related]
34. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia]. Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133 [TBL] [Abstract][Full Text] [Related]
35. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310 [TBL] [Abstract][Full Text] [Related]
36. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents. Nademanee K; Singh BN Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735 [TBL] [Abstract][Full Text] [Related]
37. Ectopic ventricular tachycardia sensitive to calcium antagonists in acute myocardial infarction in dogs. Miyazaki T; Ogawa S; Sakurai K; Mori H; Yamazaki H; Nakamura Y Am J Cardiol; 1985 Apr; 55(8):1085-90. PubMed ID: 3984871 [TBL] [Abstract][Full Text] [Related]
38. [Combination treatment of atrial arrhythmias with quinidine-verapamil]. Gülker H; Bramann HU; Brisse B; Kuhs H Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393 [TBL] [Abstract][Full Text] [Related]
39. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T; Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697 [TBL] [Abstract][Full Text] [Related]